Home/Pipeline/Ustekinumab (Localization)

Ustekinumab (Localization)

Not specified (typically psoriasis, Crohn's disease)

Not specifiedActive

Key Facts

Indication
Not specified (typically psoriasis, Crohn's disease)
Phase
Not specified
Status
Active
Company

About Pharmapark

Pharmapark is a private, revenue-generating Russian biopharmaceutical company established in 2003, operating as a full-cycle developer and manufacturer of biological drugs. It has a diversified business model combining proprietary in-house product development with extensive contract manufacturing and localization services for international partners. The company's strategy leverages its GMP-certified production facilities, R&D center, and a network of global partnerships to bring both generic and original biologics to the Russian market and beyond.

View full company profile